Longitudinal and cross-sectional associations of myocardial stress markers with kidney function and chronic kidney disease in the BiomarCaRE project
View Full PaperWhy the study?
Are elevated levels of myocardial stress markers (MR-proADM, MR-proANP, NT-proBNP) associated with reduced kidney function and higher prevalence/incidence of chronic kidney disease in the general population?
Population
61,830 participants from the general European population, mean age 51.8 years, 52.1% female. Longitudinal…
Comparison
Elevated levels of myocardial stress markers… vs Lower levels of the same myocardial stress markers
Design
Cohort
Follow-up
mean 11.1 ± 2.49 years (for longitudinal analysis)
Key result
Higher levels of NT-proBNP were associated with a 2.35 ml/min/1.73m2 lower eGFR (per 1 SD increase) and a 1.81-fold higher odds of prevalent CKD cross-sectionally, and with a 1.37 ml/min/1.73m2 faster 10-year eGFR decline and 1.39-fold higher risk of incident CKD longitudinally in a European general adult population.
Authors
Loading...
NT-proBNP may flag higher CKD risk in general adults; extends prior cardio-renal associations longitudinally but leaves causality open.
Observational (n=61,830)
Yes
Are elevated levels of myocardial stress markers (MR-proADM, MR-proANP, NT-proBNP) associated with reduced kidney function and higher prevalence/incidence of chronic kidney disease in the general population?
Higher levels of myocardial stress markers (MR-proADM, MR-proANP, and NT-proBNP) are significantly associated with lower kidney function and higher prevalence and incidence of chronic kidney disease in the general population.
Effect estimate: Cross-sectional: For each 1 SD increase in log-transformed NT-proBNP, eGFRcr-cys decreased by 2.35 ml/min/1.73m2; Odds ratio (OR) for prevalent CKDcr-cys was 1.81 (95% CI 1.72–1.90); Highest NT-proBNP group (≥300 pg/ml) had OR 5.72 (95% CI 4.82–6.78) vs lowest group (<48 pg/ml). Longitudinal: For each 1 SD increase in log-transformed NT-proBNP, 10-year decline in eGFRcr-cys was –1.37 ml/min/1.73m2 (95% CI –1.77 to –0.98); Hazard ratio (HR) for incident CKDcr-cys was 1.39 (95% CI 1.20–1.62); Highest NT-proBNP group had HR 4.40 (95% CI 2.63–7.36) vs lowest group. (95% CI As stated above.)
p-value: p=All associations statistically significant with p<0.05, many p<0.001
Lin et al. (2026) conducted an observational in General adult population from Europe with variable cardiovascular disease and diabetes status, assessed for kidney function and chronic kidney disease (n=61,830). Higher levels of myocardial stress markers (NT-proBNP, MR-proANP, MR-proADM) vs. Lower levels of these markers (group 1) was evaluated on Kidney function measured by estimated glomerular filtration rate (eGFRcr-cys) and prevalence/incidence of chronic kidney disease (CKDcr-cys defined as eGFR < 60 ml/min/1.73m2) (Cross-sectional: For each 1 SD increase in log-transformed NT-proBNP, eGFRcr-cys decreased by 2.35 ml/min/1.73m2; Odds ratio (OR) for prevalent CKDcr-cys was 1.81 (95% CI 1.72–1.90); Highest NT-proBNP group (≥300 pg/ml) had OR 5.72 (95% CI 4.82–6.78) vs lowest group (<48 pg/ml). Longitudinal: For each 1 SD increase in log-transformed NT-proBNP, 10-year decline in eGFRcr-cys was –1.37 ml/min/1.73m2 (95% CI –1.77 to –0.98); Hazard ratio (HR) for incident CKDcr-cys was 1.39 (95% CI 1.20–1.62); Highest NT-proBNP group had HR 4.40 (95% CI 2.63–7.36) vs lowest group., 95% CI As stated above., p=All associations statistically significant with p<0.05, many p<0.001). Higher levels of NT-proBNP were associated with a 2.35 ml/min/1.73m2 lower eGFR (per 1 SD increase) and a 1.81-fold higher odds of prevalent CKD cross-sectionally, and with a 1.37 ml/min/1.73m2 faster 10-year eGFR decline and 1.39-fold higher risk of incident CKD longitudinally in a European general adult population.